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MCS: A Sensitive Issue
Dianne Wiganowsky heard an unusual
noise outside her house in Cheyenne,
Wyoming, in September 1992, so she went
to look out her screen door. She did n t
expect the potent stream oflawn c i
that struck her in the face, n cou shL
know that, at that me r alth
would begin to din th point that
most ofher time is svrlnitoring pain.
What hit Wigan sky was a strong
mix of active agricultural organophos-
phates and fungicides that a lawn care
company was spraying, carelessly, with a
bullet nozzle on a neighbor's shrubs and
trees. The powerful stream hit Wiganow-
sky at the door with such velocity that the
chemical mixture ran down the rear wall of
her living room.
Two days later she had "the worst flu
in the world," followed by lethargy so
severe she couldn't get out ofbed, succeed-
ed by pneumonia. She visited five different
doctors, all of whom couldn't find any-
thing wrong, and all ofwhom referred her
to a psychiatrist. When Wiganowsky, 54,
went outside, her eyes turned red and
bloodshot, her lips cracked and bled, and
pain roamed her body, settling in different
areas.
Eventually, Wiganowsky got sick after
bathing because of chlorine in her water,
and she stopped using her favorite sham-
poo when it burned her scalp. She can't
stand the prickly pain she experiences after
using deodorant or lipstick, and a whiff of
perfume makes her nauseated and sick.
After sitting on the carpet in a friend's new
home, Wiganowsky got blisters on her
thighs. She is now engaged in an unhappy
struggle to avoid nearly everything.
Until recently, most physicians, like
the ones Wiganowsky first saw, would refer
such patients to a psychiatrist. Many still
do. But a segment of the medical profes-
sion is giving more and more credence to
evidence suggesting that Wiganowsky and
others are victims of an illness that has
been variously dubbed environmental ill-
ness, total allergy syndrome, chemical
AIDS, and, most commonly, multiple
chemical sensitivity (MCS). Some patients
and physicians call MCS "20th-century ill-
ness" because they believe it is caused by a
growing environmental load of chemicals
in the modern world. To someone who has
become sensitized to these chemicals, sniffs
of such common products as hair spray
and laundry soap produce myriad symp-
toms, including headaches, rashes, depres-
sion, confusion, and fatigue.
After talking with all the experts she
could find, including the Centers for
Disease Control, Wiganowsky now knows
pesticides on airplanes that land in their
countries because passengers were getting
sick. The State of California proposed a
that MCS is not recognized by many bill to ban perfume in the workplace. And
physicians. So, to control her consta the popular television show "Northern
pain, Wiga ows throws away anyt ExpoLre" featured a chemically sensitive
tha es er Hir. But what bother er attor who lived in a toxic-free geodesic
X0o e s, Rat many people th do aska, isolated from the toxins of
yoinoms like hers are dismissed by s in tri nation and mainstream society.
as wackos. "There can't be so many people ple cept that some indi-
that are crazy in a similar way. All I ask for viduals a se o chemicals and that
is a benefit of the doubt," she said. That they may suff&rying degrees of illness.
may be as much as the scientific communi- In fact, one survey found thjt up to 30%
ty is willing to give. MCS is perhaps medi- ofthe population thi lay be some-
cine's most controversial disorder-if it what sensitive to chenicals; evere prob-
can even be called a disorder. lems are reported by 2 H epeople.
Even segments of i ral govern-
Recognition ofa Problem ment seem to be sever ahead ofthe
The malady is one that baffles medical scientific community in their willingness
experts. They disagree whether MCS is to accept chemical ser vity. In 1990, the
real, and they argue over its definition, eti- Americans with Disbil t included
ology, and treatment. Detractors point out MCS as a recognized condition, and by
that most who suffer from MCS have a mid-1992, the p ent of Housing
lifelong history ofmedical problems which and Urban Developrejt established dis-
usually includes depression, and they won- ability statF the Horder. Congress has
der why it seems to strike mostly white, even hel e s on whether the chemi-
middle-aged, middle-class women. Most cals i; car s use sick-building syn-
academic allergists and immunologists dra whichis thought to be caused by
reject an MCS diagnosis as unconventional chemi and inadequate ventilation sys-
and unproven, pointing to little evidence tems in Wplaces. Some people who suf-
of immune system dysfunction. Patient fer from siX building syndrome go on to
who can't find solace in the hands ofe 1%m_ develop MCS.
lishment medicine turn to a breed Wf'1- Organized support groups for MCS
ical practitioners called "clinical S4ists" victims have sprung up in the last decade,
who believe that single or mjpkexpo- and some have succeeded in pushing
sures to a wide range of iem als, even research money through Congress. Mary
foods, can cause super nsiity. More Lamiella, founder and president of the
than 20 patient-suppprt vsletters are National Center for Environmental Health
published annually, arlPne ofthe terms Strategies, says that she sees new signs of
they use to describe lves are "univer- acceptance of MCS everywhere but in the
sal reactors," "chemi and "canaries." lawsuits that chemical companies are fight-
Other patients, the controversy, ing and in the medical and scientific main-
tell their friends theysq r from a more stream establishment.
politically corre chronic fatigue "Things have changed. A lot of indus-
syndrome, wrich so people believe try groups, such as those that make pesti-
overlapswith cides or perfumes, no longer deny that
The scientific centers around there is a problem. They are jumping on a
this question: is MCS a real inical condi- bandwagon in a sense, because they fear
tion, a form ofpsychiatric illness, or, as has consequences if they don't respond," says
been recently proposed, a combination of Lamiella.
both? There is a growing number ofclini-
cal observations c a patients who
report m!"it )Nesrcl ties and
invest 7lot a-
ih s has been further the
p X he point of some tance.
Advertisers now tout dishwashi deter-
gent that contains no perfumes or dyes. In
June, the U.S. Department of Transpor-
tation asked foreign countries not to spray
Arousing Interest
Lamiella admits that the economic stakes
are high in whether MCS is ever recog-
nized as a medical condition-insurers,
government agencies that provide medical
care and compensation, the chemical
industry, and others are already being hit
with claims and lawsuits, and more would
surely follow. But she also claims that "it is
only the established medical research com-
munity that is comfortable saying that
there isn't a problem, and that they don't
have any money [for research] anyway."
Indeed, MCS is not recognized by the
Centers for Disease Control; it has no
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diagnostic criteria or tests, nor is a case def-
inition expected soon. The list of symp-
toms and chemical culprits changes from
patient to patient, but common complaints
can include fatigue, concentration or
memory difficulties, irritability, nervous
tension, depression, daytime drowsiness,
food cravings, insomnia, headaches, nasal
congestion, muscle and joint aches, ringing
in the ears, gastrointestinal distress, and
palpitations.
No one knows how many people are
sensitive to chemicals. And some physi-
cians who don't believe in MCS call others
who do quacks. There is, as Lamiella said,
surprisingly little money to research the
phenomenon; the few studies undertaken
are done using "found" funds-monies
borrowed from other research studies.
Government officials say publicly that
they are neutral about the issue; some pri-
vately add that they are protecting them-
selves against a political backlash. They
also note that numerous symposia con-
vened around MCS, such as the National
Research Council's 1991 meeting, have
gone nowhere. But despite the skepticism,
new views of the interactions between
brain and body have caused some regula-
tors and a handful of scientists to take
note.
The group taking the lead on MCS is
the CDC's sister, the Agency for Toxic
Substances and Disease Registry (ATSDR),
which is trying to put together an intera-
gency working group to study the issue.
Participants will include government agen-
cies such as the National Institute of
Occupational Safety and Health, several
branches of Health and Human Services,
including the National Institutes ofHealth
and the National Institute of Environ-
mental Health Sciences, the EPA, and the
Departments of Agriculture, Defense,
Veterans Affairs, andJustice.
The working group is an effort to get
the dialogue on MCS underway, said Barry
Johnson, assistant administrator forATSDR
"There are serious questions that remain in
terms ofresearching the clinical expression
and symptoms of MCS," said Johnson.
"But what is not, in my mind at least, in
question is that some people are in health
distress."
Johnson continued, "This is an issue
that theATSDR has chosen to take serious-
ly, and we want to bring light to a dim sub-
ject. But there is no simple path to getting
on with scientific and clinical issues. I can-
not guarantee that even when we all come
together, there will be agreement that there
is a need for coordinated activity."
A New Name for an Old Problem-
Chemical sensitivity may not be new. The
reclusive, asthmatic French novelist Marcel
Proust (1871-1922) spent the last years of
his life in a cork-lined bedroom in Paris.
He warned visitors not to wear perfume.
A medical syndrome ofchemical sensi-
tivity was first described in 1951 by
Chicago allergist Theron Randolph, who
noted that several of his patients had a
"petrochemical problem" in that they
became ill when passing through the heavi-
ly industrialized areas ofnorthwest Indiana
and South Chicago. He advised patients to
avoid a wide range of everyday chemical
exposures and food to see whether they
improved.
His followers, who became known as
"clinical ecologists," began to treat self-report-
ing patients who could find no reliefwith
mainstream medicine. They used a variety of
practices, including sauna therapy, vitamin
and mineral supplementation, and sublingual
or intradermal administration ofchemicals to
diagnose and treat the condition.
These practices and diagnoses have
resulted in an ongoing acrimonious debate.
Allergists have called clinical ecologists
"pseudoscientists," convincing many in
medicine that the diagnoses and treatment
used by clinical ecologists are unproven and
ineffective. "I have seen nothing to demon-
strate that [MCS] exists," William Waddell,
chair ofpharmacology and toxicology at the
University ofLouisville School ofMedicine,
told the journal Science. He blamed the syn-
drome on an "irrational fear of man-made
chemicals." Others go further, accusing
clinical ecologists of brainwashing their
patients, who did not know what was
wrongwith them, into believing their illness
springs from chemicals.
A stinging rebuke of clinical ecology
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was published in a July 1989 position
paper inAnnalsofInternalMedicine
Clinical ecology lacks scientific validation,
and the practice of "environmental medi-
cine" cannot be considered harmless.
Severe restraints are placed on patients'
lives, and in many cases, invalidism is rein-
forced as patients develop increasingly
iatrogenic disability. Treatment by dinical
ecologists frequently creates a severe finan-
cial burden for patients and imposes signif-
icant costs on health insurers and worker's
compensation issues.
Fueling this dissent was a spate of
reports that suggested clinical significance
to the disorder. Specifically, support for
MCS sufferers came in 1989 when a study
commissioned by the New Jersey Depart-
ment ofHealth was issued. The study was
conducted by Nicholas Ashford, a chemist
and lawyer who is an associate professor of
technology and policy at the Massachusetts
Institute of Technology, and Claudia
Miller, an allergist and immunologist at
the University of Texas Health Science
Center in San Antonio. Their study con-
cluded that chemical sensitivity is "wide-
spread in nature and is not limited to what
some observers would describe as maling-
ering workers, hysterical housewives, and
workers experiencing psychogenic illness."
Ashford and Miller found evidence of
chemical sensitivity in industrial workers,
occupants of"tight buildings" with no air
flow to the outside, people who live in
communities where the water and air are
contaminated by toxic chemicals, and
other people exposed to chemicals in con-
sumer products, drugs, and pesticides. The
researchers said that while no definitive
conclusions were possible, "chemical sensi-
tivity does exist as a serious health and
environmental problem, and public and
private sector action is warranted at both
the state and federal levels."
In 1991, Ashford and Miller wrote a
book, Chemical Exposures: Low Levels and
High Stakes, that reviewed MCS literature
and proposed biological models ofthe dis-
order. Those who consid-
ered the syndrome to be
due to psychological fac-
tors began their own stud-
ies. For example, John
Selner, an allergist and res-
piratory specialist at the
University of Colorado
Health Sciences Center in
Denver, claims he can cure
most of his MCS patients
by systematically depro-
gramming them to elimi-
nate their "false" beliefs"
Et I r about chemicals. Lne ot BauyJohnson-
the most vocal critics of in question istha
MCS, Abba Terr, a profes- pie areinhealth
sor of medicine at
Stanford University,
thinks chemophobia is at
the root of these patients'
illness, although he has




study, reported in the 15
July 1993 issue of the
Annals ofInternal Med-
icine, found no physiolog-
ic differences between
MCS patients and con-
trols, except that MCS ClaudiaMiller-C
patients had more depres- is not limited to m
sion, Terrwrote an editor- orhysterical house
ial that suggested physi-
cians treat MCS patients with behavior
modification therapy. "Seasoned internists,
other primary care physicians, and special-
ists recognize in these patients an all-too-
familiar pattern ofover-utilization ofmed-
ical diagnostic facilities because of long-
standing unexplained symptoms," he
wrote. "The only thing that distinguishes
environmental illness or multiple chemical
sensitivity from this pattern is the attribu-
tion of symptoms to environmental expo-
sures." Other journals weighed in. In
1992, the Journal oftheAmerican Medical
Association published a report from its
Council on Scientific Affairs, concluding
that MCS "should not be considered a rec-
ognized clinical syndrome."
Stories and Studies
At the same time, a handfil ofresearchers
pursued physiological mechanisms that
could explain MCS. What they have to
work with is, in large part, anecdotal evi-
dence that paints a common picture.
"Anecdotal stories are just that, but they
become very powerful when they come
from so many different people across the
country," says Lamiella.
Generally, many patients can identify
specific circumstances that initiated their
illnesses. Some say it began after
an overwhelming exposure to
_ chemicals, such as a spill on their
job or exposure to pesticides; an
informal survey of almost 7000
self-reported chemically sensitive
people say their illness started
with a pesticide exposure. Or
MCS can come on after a new,
chronic, medium-level exposure,
such as moving into a new house
with significant emissions of
volatile organic compounds from
the building materials or the car-
-Wt
dist
iatis not pet. After the initial event, symp-
)me peo- toms seem to wax and wane with




When patients think they
know the source of the
irritant and remove it,
symptoms disappear.
Once the syndrome




izes from the original trig-
ger to low doses of multi-
ple, chemically unrelated
substances, such as per-
fume, tobacco smoke, auto
exhaust, and newsprint. A
majority of patients also
report new sensitivities to
common foods, alcoholic
beverages, and drugs they
have taken foryears.
To explain this spreading ofsensitivity,
some clinical ecologists theorize that initial
high-level exposure, or chronic low-level
exposure to chemicals causes the immune
system to overreact to subsequent expo-
sures or to lose some of its ability to pro-
tect the body against harmful substances.
The immune system, they point out, also
carries out precise regulatory interactions
between itself and the endocrine and ner-
vous systems, so a dysfunctional immune
system could possibly lead to a multitude
ofsymptoms.
One study, conducted by Alan Levin,
professor ofimmunology at the University
of California at San Francisco, found that
some components of immunity can be
abnormal in MCS patients. He found that
T-cell and B-cell counts and the ratio of
helper T- to suppressor T-lymphocytes are
altered in these patients. Similarly, William
Rea, a clinical ecologist in Dallas, Texas,
reported abnormal levels of complement,
T-lymphocytes, red blood cells, and
immunoglobulin G in his patients.
But research findings on immune sys-
tems ofMCS patients have not been con-
sistent; to date, no single, consistently
abnormal immunological parameter has
been found in these patients. Terr, for
example, found normal levels of
immunoglobulins, complement compo-
nents, and lymphocyte subsets in a review
ofthe medical records of50 patients diag-
nosed with the disorder. Many allergists
point out that formaion of IgE, the
immunoglobulin associated with allergy, is
very specific for particular substances, such
as ragweed or bee venom, and that it can-
not be spread to chemically unrelated sub-
stances.
All in the Head
Now research into MCS has delved into
otherphysiologic pathways, many ofwhich
center on nervous system interactions. One
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scientist, William Meggs, of the Depart-
ment of Emergency Medicine at East
Carolina University School of Medicine,
believes that volatile organic chemicals irri-
tate fibers in the airway, leading to inflam-
mation, and then to systemic symptoms.
The inducing exposure may alter the regu-
lation of respiratory mucosa in such ways
that subsequent chemical exposure would
result in a heightened inflammatory re-
sponse.
Other scientists, including two leading
MCS researchers, Miller and Iris Bell of
the Department of Psychiatry at the
University of Arizona Health Sciences
Center, are postulating an "integrated"
MCS hypothesis that ties the biological
and psychiatric elements ofMCS together.
The key, they say, is the rich neural con-
nections that lie between the olfactory sys-
tem and the limbic and temporal regions
in the brain's cerebral hemispheres, which,
in part, regulate mood and autonomic
functioning. They argue that many envi-
ronmental chemicals gain access to the
central nervous system via the olfactory
and limbic pathways, inducing lasting
changes in limbic neuronal activity and
overall cortical arousal levels, altering a
broad spectrum of behavioral and physio-
logical functions to produce clinical MCS
syndromes.
The limbic system is adjacent to the
olfactory bulb, which contains nerves that
are the brain's most direct contact with the
external environment; there is no protec-
tive blood-brain barrier. Each olfactory
nerve consists ofbipolar neurons with one
end in the upper part of the nose and the
other in the brain's olfactory bulb. Odors
can elicit electrical activity in the amygdala
and hippocampal areas of the limbic sys-
tem via this pathway. And subsensory
exposure to chemicals can cause protract-
ed, if not permanent, alterations in the
electrical activity of the limbic region,
beginning first with the most sensitive
structures, such as the part ofthe amygdala
that analyzes odor, says Miller.
The amygdala, the most sensitive por-
tion of the brain to chemical stimuli, has
been dubbed "emotion central," according
to Miller. It is involved in feelings and
activities related to self-preservation, such
as hunger and the fight-or-flight response,
and it is important in regulating mood
states.
Furthermore, the hippocampus, impor-
tant in learning and memory, is seen by
some researchers as a prime target for tox-
ins. Damage to the hippocampus may
affect the synthesis, storage, release, or
inactivation of excitatory and inhibitory
amino acids that serve as neurotransmitters
in this area ofthe brain. The hippocampus




Sniffing out clues. Researchers hypothesize that environmental chemicals that gain access to the brain
through the olfactory and limbic pathways may alter behavioral and physiological functions to produce
MCS syndromes.
drinking, digestive and metabolic activities,
aggressive behavior, and physical manifes-
tations of emotion such as increased heart
rate and elevated blood pressure. The hip-
pocampus is also the area where the sym-
pathetic and parasympathetic nervous sys-
tems converge. Says Miller, "Many symp-
toms that patients experience with food
and chemical activities could be related to
the autonomic nervous system."
Bell has taken the model a step further
to postulate that these systems are so inter-
twined that dysfunction in either can pro-
duce emotional problems or chemical sen-
sitivity, and vice versa. "The olfactory sys-
tem, hypothalamus, and limbic system
pathways would provide the neural circuit-
ry by which adverse food and chemical
reactions could trigger certain neural, psy-
chologic, and psychiatric abnormalities,"
said Bell, adding that patients with chemi-
cal sensitivities have reported food crav-
ings, binges, violence, or hypersexual activ-
ity following chemical exposure.
Bell also thinks that traumatic psy-
chosocial events, like childhood abuse,
could trigger changes in limbic activities,
such as a heightened sensitivity to chemi-
cals, that can result in MCS. She said that
there is no question that the majority of
MCS patients have a history of depres-
sion-many studies profiling MCS
patients have pointed that out. Her own
studies of college students and the retired
elderly in Tucson who have reported some
sensitivity to chemical exposure have found
elevated rates of "generalized distress and
negative affectivity, including depression,
anxiety, and irritability." This relationship
between depression and physiological
symptoms is, of course, the old chicken-
and-egg question. Many MCS detractors
say that the depression influences the
degree to which a patient rates symptoms
oftheir malaise.
To back her theory, Bell cites interest-
ing, albeit divergent, lines of evidence. In
her surveys, she found that a self-reporting
of shyness correlated most often with
chemical sensitivity. And in animal models
of shyness, if the amygdala is stimulated,
the animal increases avoidance behavior.
Psychologists have long thought of the
amygdala and limbic systems as regulators
of social interaction and emotional tone,
says Bell. That area ofthe brain is also the
first place that gets information about nox-
ious smells. Ifa patient acquired a vulnera-
bility in the limbic system different from a
"normal" person, he or she may be more
prone to olfactory stimuli. Removal ofthe
olfactory bulb in laboratory animals serves
as a model for depression that researchers
have used to test the effectiveness of anti-
depressant drugs, Miller says.
One study may underscore Miller and
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Bell's hypothesis. To understand what
symptoms MCS patients share in com-
mon, researchers at the Robert Wood
Johnson Medical School in New Jersey
comprehensively analyzed 11 patients con-
sidered "pure"-they had no previous
physical or psychiatric conditions to
explain their symptoms, nor were they
under the care ofa clinical ecologist or part
of an MCS support group. "Therefore,
they were not simply repeating patterns
that had been suggested to them," says
Howard Kipen, associate professor at the
medical school and at the Environmental
and Occupational Health Sciences
Institute (EOSHI).
What Kipen and colleagues found is
that none of the subjects showed medical,
allergic, or immunologic abnormalities, or
premorbid psychiatric conditions, but that
all had an increased sensitivity to odors,
and six of them had poor memory perfor-
mance on functional tests which were con-
sistent with some form of central nervous
system dysfunction. What was not clear,
however, was how the patient's psychologi-
cal disposition (some of them were
depressed and anxious) interacted with the
CNS symptoms, mediated through smell.
"The psyche sits on the CNS," said Kipen.
To help answer this question, Kipen
will use a facility built at EOSHI for test-
ing air pollutants to conduct studies in
which MCS patients will be exposed to
chemicals at such a low threshold that
patients won't be able to smell them. Any
symptoms patients report
will be followed by physio-
logical tests, said Kipen.
An integral part of Bell's
model are the processes by
which the limbic system is
sensitized, which she calls
"time-dependent sensitiza-
tion" (TDS) and "kindling."
A TDS model "predicts that
finding that either a chemical
exposure event or a stressful
life event at the initiation
point of illness in an MCS
patient increases, not decreas-
es, the likelihood of future
amplified reactivity to both
chemicals and stress," said Bell. Kindling, a
very specific type of TDS, is best seen
when animals are given enough low levels
of electrical stimuli to induce a seizure,
even though the stimuli is not enough to
produce a seizure on its own. Subse-
quently, the process becomes permanent-
seizures are always produced on low volt-
age. An analogous phenomenon is seen in
psychiatry; an important psychosocial
event triggers a first episode, and the disor-
der then begins to be repeated with smaller
and smaller events.
Bell says that animal experiments have
found such cross-overs in that stress to an
animal can set offneuronal sensitivity. She
added that female animals have shown
greater susceptibility to TDS, accounting,
perhaps, for the large percentage of MCS
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patients who are women. Bell
said that, in her view, MCS
has more in common with
post-traumatic stress disorder
than with sick-building syn-
drome, to which it is usually,
and erroneously, compared.
Johnson of the ATSDR
calls Bell's hypothesis "fasci-
nating, a neat theory that ties a
lot of observations together."
But he noted, as does Bell her-
self, that no specific evidence
exists to support that view.
"There's no animal model for
MCS, and there's no federal
money to create one. The few
of us that work on MCS find a little
money in other budgets," she said.
Johnson agrees, saying that MCS
research may continue to suffer from medi-
cine's worst vicious circle: "There are clear-
ly people who are in distress, but in order
to derive a case definition for MCS to be
used by physicians to derive a diagnosis, we
need to bring some science to bear on the
debate, but it has been difficult to mobilize
funding, because, in part, there's no case
definition, nor any beliefthat there will be
one in the near future."
Renee Twombly
Renee Twombly is a freelance writer in Durham,
North Carolina.
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